INVESTIGATING THE CLINICAL OUTCOMES OF COMBINATION IMMUNOTHERAPY AND TARGETED THERAPY IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS. Biosci. Rep. 2026, 3 (01), 24-46.